RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.
about
RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
RNA chromogenic in situ hybrid ...... us in squamous cell carcinoma.
@en
type
label
RNA chromogenic in situ hybrid ...... us in squamous cell carcinoma.
@en
prefLabel
RNA chromogenic in situ hybrid ...... us in squamous cell carcinoma.
@en
P2093
P1433
P1476
RNA chromogenic in situ hybrid ...... us in squamous cell carcinoma.
@en
P2093
Javier E Mendez-Pena
Mai P Hoang
Vania Nose
P304
P356
10.1016/J.HUMPATH.2017.02.021
P407
P50
P577
2017-03-13T00:00:00Z